Abstract
Pure Red-Cell Aplasia and Recombinant Erythropoietin (Correspondence, N Engl J Med 2002:346;1584-1586). On line 6 of the second paragraph of the response by Casadevall and Mayeux, the statement that “2 received Neorecormon exclusively” should have read “1 received Neorecormon exclusively, 1 received Eprex and Neorecormon during the months preceding the onset of anemia.”

This publication has 0 references indexed in Scilit: